Back to Interventions
Substance / Medication

Luliconazole

SNOMED 724031004UMLS C1956280

Overview

Active Ingredient
luliconazole
RxNorm CUI
1482680

Indications

Trichophyton rubrum Epidermophyton floccosum Luliconazole Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organismsand.

Labeler: Oceanside PharmaceuticalsUpdated: 2020-04-30T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

None.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Mycosis

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and tolerability of luliconazole cream 1% for dermatophytoses: a meta-analysis.
Feng Xiaowei, Xie Jinwei, Zhuang Kaiwen et al. · J Dermatol · 2014
PMID: 25156082Meta-Analysis
Comparing emollient use with topical luliconazole (azole) in the maintenance of remission of chronic and recurrent dermatophytosis. An open-label, randomized prospective active-controlled non-inferiority study.
Pathania Yashdeep Singh, Cds Katoch, Kumar Ashok · Mycoses · 2024
PMID: 37837226RCT
Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
Rana Deval K, Shah Tithi S, Rohit Mansi H et al. · Mycoses · 2024
PMID: 38214352RCT
The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: A randomized, controlled trial.
Zhou Bing Rong, Lu Yan, Permatasari Felicia et al. · Medicine (Baltimore) · 2016
PMID: 27858846RCTFull text (PMC)
A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
Nakamura Akihiro, Hirakawa Satoko, Nagai Hiroaki et al. · Med Mycol · 2021
PMID: 33539539ObservationalFull text (PMC)
Luliconazole, an alternative antifungal agent against Aspergillus terreus.
Zargaran M, Taghipour S, Kiasat N et al. · J Mycol Med · 2017
PMID: 28483449Observational
Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.
Shokoohi Gholam Reza, Badali Hamid, Mirhendi Hossein et al. · Antimicrob Agents Chemother · 2017
PMID: 28848012ObservationalFull text (PMC)
[In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
Maeda Jun, Nanjoh Yasuko, Koga Hiroyasu et al. · Med Mycol J · 2016
PMID: 26936346Observational
In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
Baghi Nesa, Shokohi Tahereh, Badali Hamid et al. · Med Mycol · 2016
PMID: 27118804Observational
A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
Jones Terry M, Jarratt Michael T, Mendez-Moguel Ines et al. · J Drugs Dermatol · 2014
PMID: 24385117Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Luliconazole (substance)
SNOMED CT
724031004
UMLS CUI
C1956280
RxNorm CUI
1482680
Labeler
Oceanside Pharmaceuticals

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.